Pfizer failed the third phase of their Lyrica-neuropathic pain study.
A major scientific breakthrough in HIV treatment will soon end up the daily treatment that each HIV patient goes through.
Pfizer's anti-smoking drug Champix does not raise the risk of depression, suicide and heart disease, according to a new study.
The US FDA has updated Chantix's label to include seizure, suicidal thoughts, among other experiences that patients might feel while under the influence of the drug.
